<div id="readability-page-1"><div>Dublin, Jan. 20, 2025 (GLOBE NEWSWIRE) -- The &#34;United States Contrast Media Injectors Market Outlook to 2033 - Computed Tomography (CT), Magnetic Resonance Imaging (MRI) and Angiographic Injectors&#34; report has been added to ResearchAndMarkets.com's offering.This is a comprehensive databook report, covering key market data on the United States Contrast Media Injectors market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Computed Tomography (CT), Magnetic Resonance Imaging (MRI) and Angiographic Injectors.The United States Contrast Media Injectors Market report provides key information and data on:</div><div>Key Topics Covered1 Table of Contents 1.1 List of Tables 1.2 List of Figures2 Introduction 2.1 What Is This Report About? 2.2 Contrast Media Injectors Market Segmentation 2.3 Definitions of Markets Covered in the Report3 Contrast Media Injectors Market, United States 3.1 Contrast Media Injectors Market, United States, Revenue ($m), 2018-2033 3.2 Contrast Media Injectors Market, United States, Volume (Units), 2018-2033 3.3 Contrast Media Injectors Market, United States, Average Price ($), 2018-2033 3.4 Contrast Media Injectors Market, United States, Distribution Share by Revenue ($m), 2023 3.5 Contrast Media Injectors Market, United States, Company Share by Revenue ($m), 20234 Overview of Key Companies in United States, Contrast Media Injectors Market 4.1 Imaxeon Pty. Ltd. 4.1.1 Company Overview 4.2 Guerbet S.A. 4.2.1 Company Overview 4.3 Bracco Imaging S.p.A. 4.3.1 Company Overview5 Contrast Media Injectors Market Pipeline Products6 Financial Deals Landscape 6.1 Debt Offerings 6.1.1 GE HealthCare Technologies Prices USD1 Billion in Public Offering of 4.800% Senior Notes Due 2029 6.1.2 Merit Medical Raises USD650 Million in Private Placement of 3% Convertible Senior Notes Due 2029 6.2 Equity Offerings 6.2.1 GE HealthCare Technologies Prices to Raise USD1.29 Billion in Upsized Secondary Offering of Shares7 Recent Developments 7.1 Financial Announcements 7.1.1 Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance 7.1.2 Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024 7.1.3 Jan 18, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2023 Results on February 6, 2024 7.2 Government and Public Interest 7.2.1 Feb 14, 2024: GE HealthCare Management to Present at Upcoming Investor Conferences8 Appendix 8.1 Research Methodology 8.1.1 Coverage 8.1.2 Secondary Research 8.1.3 Primary Research 8.1.4 Market Modeling and Forecasting 8.1.5 Company Share Analysis 8.1.6 Distribution Share Analysis 8.1.7 BenchmarkingFor more information about this report visit https://www.researchandmarkets.com/r/oejt6y</div>About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.</div>

GEHC

Merit醫療系統

《美國對比劑注射器市場展望至 2033 年》報告提供了關於用於 CT、MRI 和血管造影程序的對比劑注射器的美國市場的全面數據。報告包括 2018 年至 2033 年的收入、銷量和平均價格數據，以及市場細分和主要公司的概述。報告還涵蓋了最近的財務發展，包括 GE HealthCare 的公開募股和 Merit Medical 的私募。這本數據手冊為理解對比劑注射器行業的市場動態和趨勢提供了寶貴的資源

U.S. Contrast Media Injectors Market Outlook to 2033: Revenues, Volumes, and ASPs for Computed Tomography (CT), Magnetic Resonance Imaging (MRI) and Angiographic Injectors

GlobeNewswire

GE HealthCare Tech

GE Vernova

中國同輻

Altisource Portfolio

GE航空航天

美國對比劑注射器市場展望至 2033 年：計算機斷層掃描（CT）、磁共振成像（MRI）和血管造影注射器的收入、銷量和平均銷售價格